Schonfeld Strategic Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,597
Closed -$1.5M 2669
2024
Q1
$1.5M Sell
4,597
-27,537
-86% -$6.76M 0.01% 1085
2023
Q4
$6.12M Buy
+32,134
New +$6.07M 0.04% 472
2023
Q3
Sell
-15,359
Closed -$4.38M 2448
2023
Q2
$4.38M Sell
15,359
-11,262
-42% -$3.13M 0.04% 522
2023
Q1
$5.77M Buy
26,621
+11,155
+72% +$2.17M 0.06% 403
2022
Q4
$3.18M Sell
15,466
-569
-4% -$144K 0.03% 643
2022
Q3
$4.46M Buy
16,035
+11,035
+221% +$2.81M 0.04% 565
2022
Q2
$956K Sell
5,000
-9,400
-65% -$1.66M 0.01% 1049
2022
Q1
$2.99M Buy
14,400
+7,629
+113% +$1.26M 0.03% 601
2021
Q4
$1.21M Buy
+6,771
New +$1.34M 0.01% 848
2021
Q3
Sell
-7,156
Closed -$1.36M 2554
2021
Q2
$1.36M Buy
+7,156
New +$1.17M 0.01% 843
2020
Q3
Sell
-15,000
Closed -$711K 1737
2020
Q2
$711K Buy
+15,000
New +$618K 0.02% 705

Other funds holding SWAV

Schonfeld Strategic Advisors's SWAV Position: Q2 2024 in Review

Schonfeld Strategic Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,597 shares — an estimated $1.5M sold.

Schonfeld Strategic Advisors first reported a position in SWAV in Q2 2020 and held it in 11 quarters. The position peaked at $6.12M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Schonfeld Strategic Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 4,597 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.5M.
  • Schonfeld Strategic Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Shockwave Medical, Inc. Common Stock position peaked at $6.12M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.